SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (19653)4/27/1998 9:43:00 AM
From: Sung Q. Kim  Read Replies (1) | Respond to of 32384
 
Reuters:(LGND)-LIGAND <LGND.O> SAYS SMITHKLINE HAS BOUGHT 274,423 LIGAND SHRS

LIGAND <LGND.O> SAYS SMITHKLINE HAS BOUGHT 274,423 LIGAND SHRS
FOR $5 MLN
REUTERS
Copyright REUTER 09:24 04-27-98

$18.2200472 per shr?



To: WTDEC who wrote (19653)4/27/1998 9:44:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
W, Although news is not really new, LGND's price is ignoring market and up to 14 1/2 bid, 14 5/8 ask.
Actually, and interest rate hike may be a plus to Biotechs, which are not heavily tied to interest rates and provide a depressed segment for rotation.



To: WTDEC who wrote (19653)4/27/1998 10:03:00 AM
From: tonyt  Read Replies (2) | Respond to of 32384
 
Another short-lived rally -- bid back down to 14.25


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News